Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma

Robert J Harris1, Timothy F Cloughesy, Whitney B Pope

  • 1Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90024, USA.

Journal of Neuro-Oncology
|January 25, 2013
PubMed

Insights

Three-dimensional double inversion recovery (DIR) MRI sequences improve brain tumor boundary definition. DIR MRI offers higher contrast-to-noise ratio and smaller tumor volumes compared to FLAIR sequences.

Area of Science:

  • Radiology
  • Neuroimaging
  • Oncology

Background:

  • Fluid attenuated inversion recovery (FLAIR) MRI is crucial for identifying malignant brain tumor boundaries.
  • FLAIR sequences highlight edema and infiltrating tumor by suppressing cerebrospinal fluid signals.

Purpose of the Study:

  • To evaluate the utility of a 3D double inversion recovery (DIR) sequence for differentiating brain tumors from normal tissue.
  • To compare DIR sequence performance with FLAIR, T1-weighted, and DSC-MRI.

Main Methods:

  • Acquired T1-, T2-weighted, FLAIR, DSC-MRI (rCBV), contrast-enhanced T1 (T1+C), and DIR (pre/post-contrast) data in 22 glioblastoma patients.
  • Compared contrast-to-noise (CNR) and tumor volumes between DIR and FLAIR sequences.
  • Analyzed line profiles and voxel-wise associations between DIR and other MRI sequences.

Main Results:

  • Post-contrast DIR images showed hyperintensity similar to FLAIR but hypointensity in contrast-enhancing regions.
  • DIR identified significantly smaller tumor volumes (24% less) and higher lesion CNR (1.5x) compared to FLAIR.
  • DIR demonstrated positive correlation with FLAIR and negative correlation with post-contrast T1+C and rCBV.

Conclusions:

  • 3D DIR MRI provides enhanced differentiation between tumor and normal brain tissue.
  • DIR sequences offer superior lesion conspicuity and more accurate tumor volume assessment than FLAIR.
  • DIR MRI may offer valuable complementary information beyond conventional FLAIR imaging for brain tumor evaluation.